BML264

• Description :

  BML264 ((E) -N- (p-amylcinnamoyl) anthranilic acid) is an agonist for TREK-1. BML264 can be used to study diseases associated with TASK1 dysfunction[1].

• Product Name Alternative :

  (E) -N- (p-Amylcinnamoyl) anthranilic acid; (E) -ACA

• UNSPSC :

  12352005

• Hazard Statement :

  H410

• Target :

  Potassium Channel

• Type :

  Reference compound

• Related Pathways :

  Membrane Transporter/Ion Channel

• Field of Research :

  Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/bml264.html

• Smiles :

  O=C(O)C1=CC=CC=C1NC(/C=C/C2=CC=C(CCCCC)C=C2)=O

• Molecular Formula :

  C21H23NO3

• Molecular Weight :

  337.41

• Precautions :

  P273-P391-P501

• References & Citations :

  [1]Feinmark S, et al., Method of treating a condition associated with phosphorylation of TASK-1. US20070259051 A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [99196-74-4]